BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 35406769)

  • 1. Chaperone-Mediated Autophagy in Neurodegenerative Diseases and Acute Neurological Insults in the Central Nervous System.
    Kanno H; Handa K; Murakami T; Aizawa T; Ozawa H
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy.
    Liu Y; Tan L; Tan MS
    Mol Cell Biochem; 2023 Oct; 478(10):2173-2190. PubMed ID: 36695937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities.
    Wang YT; Lu JH
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperone-Mediated Autophagy in Brain Injury: A Double-Edged Sword with Therapeutic Potentials.
    Zhang H; Tian Y; Ma S; Ji Y; Wang Z; Xiao P; Xu Y
    Mol Neurobiol; 2024 May; ():. PubMed ID: 38775879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases.
    Xilouri M; Stefanis L
    Mol Cell Neurosci; 2015 May; 66(Pt A):29-36. PubMed ID: 25724482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
    Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperone-Mediated Autophagy after Spinal Cord Injury.
    Handa K; Kanno H; Matsuda M; Sugaya T; Murakami T; Prudnikova M; Ozawa H; Itoi E
    J Neurotrauma; 2020 Aug; 37(15):1687-1695. PubMed ID: 32233738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chaperone-mediated autophagy: Advances from bench to bedside.
    Li W; Nie T; Xu H; Yang J; Yang Q; Mao Z
    Neurobiol Dis; 2019 Feb; 122():41-48. PubMed ID: 29800676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy in the central nervous system: implications for neurodegenerative disorders.
    Xilouri M; Stefanis L
    CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):701-19. PubMed ID: 20942791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaperone-Mediated Autophagy: A Potential Target for Metabolic Diseases.
    Yang M; Luo S; Chen W; Zhao L; Wang X
    Curr Med Chem; 2023; 30(16):1887-1899. PubMed ID: 35959621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases.
    Wu H; Chen S; Ammar AB; Xu J; Wu Q; Pan K; Zhang J; Hong Y
    Mol Neurobiol; 2015 Dec; 52(3):1284-1296. PubMed ID: 25330936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaperone-Mediated Autophagy and Its Emerging Role in Hematological Malignancies.
    Robert G; Jacquel A; Auberger P
    Cells; 2019 Oct; 8(10):. PubMed ID: 31623164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chaperone-mediated autophagy and neurodegeneration: connections, mechanisms, and therapeutic implications.
    Liu X; Huang S; Wang X; Tang B; Li W; Mao Z
    Neurosci Bull; 2015 Aug; 31(4):407-15. PubMed ID: 26206600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperone mediated autophagy in aging: Starve to prosper.
    Xilouri M; Stefanis L
    Ageing Res Rev; 2016 Dec; 32():13-21. PubMed ID: 27484893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaperone-mediated autophagy and disease: Implications for cancer and neurodegeneration.
    Gómez-Sintes R; Arias E
    Mol Aspects Med; 2021 Dec; 82():101025. PubMed ID: 34629183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson's Disease.
    Sala G; Marinig D; Arosio A; Ferrarese C
    Front Mol Neurosci; 2016; 9():157. PubMed ID: 28066181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model.
    Xu X; Sun Y; Cen X; Shan B; Zhao Q; Xie T; Wang Z; Hou T; Xue Y; Zhang M; Peng D; Sun Q; Yi C; Najafov A; Xia H
    Protein Cell; 2021 Oct; 12(10):769-787. PubMed ID: 34291435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid droplet accumulation in Wdr45-deficient cells caused by impairment of chaperone-mediated autophagic degradation of Fasn.
    Xiong Q; Sun H; Wang Y; Xu Q; Zhang Y; Xu M; Zhao Z; Li P; Wu C
    Lipids Health Dis; 2024 Mar; 23(1):91. PubMed ID: 38539242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaperone-mediated autophagy dysfunction in the pathogenesis of neurodegeneration.
    Koga H; Cuervo AM
    Neurobiol Dis; 2011 Jul; 43(1):29-37. PubMed ID: 20643207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.